US Bancorp DE Has $98,000 Stake in Envista Holdings Co. (NYSE:NVST)

US Bancorp DE boosted its holdings in Envista Holdings Co. (NYSE:NVST) by 150.6% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 4,971 shares of the company’s stock after acquiring an additional 2,987 shares during the quarter. US Bancorp DE’s holdings in Envista were worth $98,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Hedges Asset Management LLC boosted its position in shares of Envista by 46.3% in the 3rd quarter. Hedges Asset Management LLC now owns 46,800 shares of the company’s stock worth $925,000 after purchasing an additional 14,800 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in Envista by 7.3% in the third quarter. State of Alaska Department of Revenue now owns 19,887 shares of the company’s stock valued at $392,000 after buying an additional 1,355 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in Envista by 11.2% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 15,314 shares of the company’s stock worth $303,000 after buying an additional 1,538 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Envista during the 3rd quarter worth about $31,000. Finally, Allspring Global Investments Holdings LLC increased its stake in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares during the last quarter.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, October 31st. Piper Sandler boosted their price target on shares of Envista from $16.00 to $17.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. JPMorgan Chase & Co. cut shares of Envista from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $23.00 to $16.00 in a research report on Thursday, August 8th. Evercore ISI lifted their target price on Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, Leerink Partnrs upgraded Envista from a “strong sell” rating to a “hold” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $20.71.

Envista Price Performance

NVST opened at $20.57 on Friday. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $25.64. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of -2.65, a P/E/G ratio of 2.83 and a beta of 1.30. The firm’s fifty day moving average price is $19.20 and its two-hundred day moving average price is $18.12.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.03. The business had revenue of $601.00 million for the quarter, compared to analysts’ expectations of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The business’s revenue was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.43 earnings per share. As a group, analysts anticipate that Envista Holdings Co. will post 0.72 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.